Efficacy of Integrated Exposure Therapy vs Integrated Coping Skills Therapy for Comorbid Posttraumatic Stress Disorder and Alcohol Use Disorder

随机对照试验 酒精使用障碍 退伍军人事务部 医学 暴露疗法 精神科 共病 心理干预 认知加工疗法 认知行为疗法 内科学 焦虑 生物化学 化学
作者
Sonya B. Norman,Ryan S. Trim,Moira Haller,Brittany Davis,Ursula S. Myers,Peter J. Colvonen,Erika Blanes,Robert Lyons,Emma Siegel,Abigail C. Angkaw,Gregory J. Norman,Tina L. Mayes
出处
期刊:JAMA Psychiatry [American Medical Association]
卷期号:76 (8): 791-791 被引量:103
标识
DOI:10.1001/jamapsychiatry.2019.0638
摘要

Importance

Co-occurrence of posttraumatic stress disorder (PTSD) and alcohol use disorder (AUD) is common and associated with psychiatric and functional problems. Understanding whether exposure therapy is tolerable and efficacious for treating PTSD and AUD is critical to ensure that best practice treatments are available.

Objective

To compare the efficacy of integrated (ie, targeting both PTSD and alcohol use) prolonged exposure (I-PE) therapy with present-centered integrated coping skills (I-CS) therapy, a more commonly available treatment, in reducing PTSD symptoms and alcohol use.

Design, Setting, and Participants

This prospective randomized clinical trial with masked assessments considered 186 veterans seeking Veterans Affairs mental health services. A total of 119 veterans with PTSD and AUD were randomized. Data were collected from February 1, 2013, to May 31, 2017, before treatment, after treatment, and at 3- and 6-month follow-ups. Intention-to-treat analyses were performed.

Interventions

Veterans underwent I-PE (Concurrent Treatment of PTSD and Substance Use Disorder Using Prolonged Exposure) or I-CS (Seeking Safety) therapy.

Main Outcomes and Measures

A priori planned outcomes were PTSD symptoms (Clinician Administered PTSD Scale forDSM-5) and percentage of heavy drinking days (Timeline Follow-Back) before treatment, after treatment, and at 3- and 6-month follow-ups.

Results

A total of 119 veterans (mean [SD] age, 41.6 [12.6] years; 107 [89.9%] male) were randomized. Linear mixture models found that PTSD symptoms decreased in both conditions, with a significantly greater decrease for I-PE treatment compared with I-CS treatment (treatment × time interaction, −2.83;F3,233.1 = 4.92; Cohend = 0.41;P = .002). The percentage of heavy drinking days improved in both conditions but was not statistically different between I-PE and I-CS treatment (treatment × time interaction, 1.8%;F3,209.9 = 0.18; Cohend = 0.04;P = .91).

Conclusions and Relevance

The I-PE arm had a greater reduction in PTSD symptoms than the I-CS arm and comparable drinking decreases. The study provides evidence that exposure therapy is more efficacious in treating PTSD than a more commonly available integrated treatment without exposure for comorbid PTSD and AUD.

Trial Registration

ClinicalTrials.gov identifier:NCT01601067
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
sajdhjas完成签到,获得积分10
刚刚
刚刚
冷酷丹翠发布了新的文献求助10
1秒前
柒柒应助科研小白采纳,获得10
1秒前
乐乐应助一名科研小白采纳,获得10
2秒前
fancy完成签到,获得积分10
2秒前
笨笨发布了新的文献求助10
2秒前
NexusExplorer应助家伟采纳,获得10
3秒前
余钱半两完成签到,获得积分10
3秒前
无情凡桃发布了新的文献求助10
3秒前
bb发布了新的文献求助10
4秒前
5秒前
liyongxing125完成签到,获得积分10
5秒前
坏坏的快乐完成签到,获得积分10
6秒前
夜守完成签到,获得积分10
6秒前
深情安青应助冷酷丹翠采纳,获得30
7秒前
8秒前
8秒前
9秒前
9秒前
9秒前
唐山恶少完成签到,获得积分10
9秒前
10秒前
10秒前
万能图书馆应助司空楷瑞采纳,获得10
10秒前
努力努力关注了科研通微信公众号
11秒前
12秒前
李一锐发布了新的文献求助10
12秒前
LQ发布了新的文献求助10
13秒前
13秒前
美好乐松应助周小博采纳,获得10
14秒前
15秒前
15秒前
15秒前
16秒前
hou应助科研小白采纳,获得10
16秒前
16秒前
17秒前
17秒前
麟菲发布了新的文献求助30
17秒前
高分求助中
Evolution 2024
Experimental investigation of the mechanics of explosive welding by means of a liquid analogue 1060
Die Elektra-Partitur von Richard Strauss : ein Lehrbuch für die Technik der dramatischen Komposition 1000
CLSI EP47 Evaluation of Reagent Carryover Effects on Test Results, 1st Edition 600
大平正芳: 「戦後保守」とは何か 550
Sustainability in ’Tides Chemistry 500
Cathodoluminescence and its Application to Geoscience 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3008082
求助须知:如何正确求助?哪些是违规求助? 2667320
关于积分的说明 7235257
捐赠科研通 2304544
什么是DOI,文献DOI怎么找? 1221956
科研通“疑难数据库(出版商)”最低求助积分说明 595385
版权声明 593410